Prof. Dr. Steinman's publications:

  Click here to open a new browser window with an up-to-date list of our publications.

 

Prof. Dr. Steinman's CV:

Education

BA

Dartmouth College, 1964-1968

 

Major: Physics; Minor: Russian; Phi Beta Kappa, Magna Cum Laude

MD

Harvard University, 1968-1973

 

NIH Fellow in Chemical Neurobiology at Harvard Medical School, 1970-1971

Post-graduate Training

Internship:

1973

Stanford University Hospital, Surgery

Resident:

1974

Stanford University Hospital, Pediatrics

Resident:

1977-1980

Stanford University Hospital, Pediatric and Adult Neurology

Fellow:

1975-1977

Weizmann Institute of Science, Chemical Immunology

 

1975-1976

Aharon Katzir Katchalsky Fellow

 

1976-1977

National Institutes of Health Visiting Fellow

Academic Posts

Assistant Professor:

1980-1985

Stanford University, Departments of Neurology and Pediatrics

Associate Professor:

1985-1991

Stanford University, Departments of Neurology, Pediatrics and Genetics

Professor:

1991-present

Stanford University, Departments of Neurology and
Neurological Sciences, Pediatrics

Professor:

1995-1997

The Weizmann Institute of Science

Professional Awards

1979

S. Weir Mitchell Award, American Academy of Neurology

1981-1986

Teacher-Investigator Award, National Institutes of Health (5 yr award)

1988-2002

Senator Jacob Javits Neuroscience Investigator Award from Congress of the
United States and National Institutes of Health

1994

Dr. Friedrich Sasse Award for Outstanding Contributions in Immunology from
the Free University of Berlin

Professional Organizations

  • American Academy of Neurology
  • American Neurological Association
  • American Association of Immunologists
  • Clinical Immunology Society

Board Certification

  • American Board of Psychiatry and Neurology (Neurology)

Patents

·        Immunotherapy of Autoimmune Disease, US Patent Number 4,695,459, issued 9/22/87.

·        Polypeptide Pertussis Toxin Vaccine, US Patent Number 5,000,952, issued 3/19/91.

·        Anti-T-Cell Receptor Determinants as Autoimmune Disease Treatment, Patent Serial 635202 (Australia),
3/18/93, European Application 89 401190.7-2116, allowed 3/27/95.  Patent EP 0340109B1.

·        T cell receptor variable transcripts as disease related markers. US patent 5,667,967, issued 9/16/97.

·        Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors.
US Patent 5,532,265, issued 7/2/96.

·        DNA Vaccination for induction of suppressive T cell response. US patent 5,939,400, issued 8/17/99.

Administrative Posts

Organized Midwinter Immunology Conference, Asilomar, CA

1986

Organized FASEB Autoimmunity Meeting, Vermont

1990

Organized National Multiple Sclerosis Meeting, "Immunologic Tolerance"

1991

Search Committee Department of Medicine, Stanford

1986-1987

Search Committee Magnetic Resonance Spectroscopy, Stanford 

1987-1988

Search Committee Department of Pediatrics, Stanford

1990

Search Committee Office of Technology Licensing, Stanford

1991

Institutional Planning Committee, Stanford University

1988

Medical & Scientific Advisory Committee, Myasthenia Gravis Foundation

1980-present

Special Reviewer, Immunologic Sciences Study Section, NIH

1985

Advisory Committee on Pertussis Immunization, National Institute of Medicine

1987-1990

Fellowship Advisory Committee, National Multiple Sclerosis Society

1988-1991

Medical Advisory Committee, Muscular Dystrophy Association

1990-present

Medical Advisory Committee, National Multiple Sclerosis Society

1990-1995

Task Force on Genetics, Muscular Dystrophy Association

1990-present

Member Immunological Sciences Study Section, NIH

1991-1995

Transmitting Editor International Immunology

1988-2001

Associate Editor Journal of Immunology

1991-1995

Business Positions

  • Centocor, 1991-1999, Board of Directors when sold to Johnson and Johnson
  • Neurocrine Biosciences, 1992-present, Founder, Board of Directors and Scientific Advisory Board
  • Roche Biosciences, 1998-present, Scientific Advisory Board
  • Neuronyx, 2000-present, Board of Directors and Scientific Advisory Board
  • Tolerion, 2001-present, Founder and Acting President
This website was originally designed by Dr. Christopher Lock, updated by Dr. Guy Hermans. Most recent update: 05/2002.
Best viewed with Microsoft Internet Explorer 5.0 or better.